Macular degeneration trials in Canada

In Canada 10 Also abroad 220

10 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Where
Edmonton, London, Ottawa, Toronto, Vancouver
Age
60 years and over
People
240 worldwide
Run by
ADARx Pharmaceuticals, Inc.
See details and how to joinNCT06990269 · EU 2025-521779-30-00
Phase 2Taking people
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Where
London, Ottawa
Age
50 years and over
People
272 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07441642 · EU 2025-523704-77-00
Phase 3Taking people
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Where
Ottawa, Québec
Age
50 years to 85 years
People
975 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06541704 · EU 2023-509547-27-00
No phaseNot yet taking people in Canada
MacuMira Microcurrent Stimulation for Dark Adaptation in Dry Age-Related Macular Degeneration
Where
Newmarket, Scarborough Village, Vaughan
Age
18 years and over
People
50
Run by
Clarity Eye Institute
See details and how to joinNCT07917715
Phase 2/3Completed
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Where
Edmonton
Age
60 years and over
People
274 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06635148 · EU 2022-500747-21-00
Phase 3Taking people
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Where
Ottawa
Age
50 years and over
People
561 worldwide
Run by
AbbVie
See details and how to joinNCT07007065 · EU 2024-512298-28-00
Phase 2Taking people
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Where
Boisbriand, London, Toronto
Age
55 years and over
People
324 worldwide
Run by
ONL Therapeutics
See details and how to joinNCT06659445 · EU 2024-513174-22-00
Phase 1/2Taking people
A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration
Where
Ottawa
Age
55 years to 80 years
People
62 worldwide
Run by
Kriya Therapeutics, Inc.
See details and how to joinNCT06765980
No phaseTaking people
Learning Study: Improving Vision in Adults With Macular Degeneration
Where
Waterloo
Age
18 years and over
People
30 worldwide
Run by
University of Waterloo
See details and how to joinNCT04762368
Phase 3Not yet taking people in Canada
High Dose (HD) Aflibercept Switch in Neovascular Age-related Macular Degeneration (nAMD): to Load or Maintain (HEIRLOOM)
Where
Montreal
Age
18 years and over
People
180
Run by
Clinique de Retine de l'est
See details and how to joinNCT07129239